drugset / Trial / NCT00135850

The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris

NCT00135850 ↗

Phase 1/2 Completed 48 enrolled Rigshospitalet, Denmark
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study was to evaluate the mobilization of non-haematopoietic mesenchymal and haematopoietic stem cells from the bone marrow with granulocyte colony stimulating factor (G-CSF) treatment alone and in combination with vascular endothelial growth factor (VEGF) gene therapy in patients with severe chronic occlusive coronary artery disease.

Timeline

Start
2003-03
Primary completion
2005-02
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject VEGF-A165 plasmid Other / unclassified — Other

Indications